James G. McEwen Law Blog

In M HL Tek, LLC v. Nissan Motor Co.,
99 USPQ2d 1681 (Fed. Cir. 2011), MHL Tek, LLC (“MHL”), the controversy
surrounds the ownership of U.S. Patent Nos. 5,663,496 (“the ¿496
patent”), 5,741,966 (“the ¿966 patent”), and U.S. Patent No. 5,731,516
(“the ¿516 patent”), all of which relate to... Read More

In Duramed Pharmaceuticals, Inc v Paddock Labritories, Inc., 644 F3d 1376, 99 USPQ2d 1388 (Fed. Cir. 2011), Duramed (now known as Teva Women’s Health Inc.) owns U.S. Patent No. 5,908,638 (‘638 patent.), which is directed to estrogen pharmaceutical compositions.  When originally filed, original independent claim 1 recited a conjugated estrogen pharmaceutical composition “coated with a moisture barrier coating,” and original dependent claim 7 limi... Read More

By Grant Gildehaus and James G. McEwenEver since June 8, 2005, Representative Lamar Smith, then Chairman of the House Subcommittee on Courts, the Internet, and Intellectual Property, along with several co-sponsors, have attempted to change the U.S. patent system.  In 2005, this was through introduction of H.R. 2795.  Popularly known as the “Patent Reform Act of 2005 ,” the Patent Reform Act was an omnibus bill which overhauled multiple aspects of patent practice.  Whil... Read More

Stein McEwen, LLP would like to congratulate Dr. Alan Ehrlich for being named a member of the 2011 Fellows of the American Chemical Society (ACS).  The ACS established the Fellows Program “to recognize members of ACS for outstanding achievements in and contributions to Science, the Profession, and the Society.” Dr. Ehrlich will be... Read More